Background Benzodiazepines and Z-drugs are used to treat complaints like insomnia, anxiety and pain. These drugs are recommended for short-term use only, but many studies report long-term use, particularly in older people. Objective The aim of this study was to identify and synthesise qualitative studies exploring patients' experiences and perceptions of receiving benzodiazepines and Z-drugs, and through this identify factors which perpetuate use of these drugs, and strategies for achieving safer prescribing.
Introduction
Benzodiazepines (e.g. diazepam, temazepam, lorazepam [BZDs] ) and Z-drugs (e.g. zopiclone, zolpidem, zaleplon) are commonly prescribed for insomnia, and are also used to manage anxiety and pain. Guidelines suggest that if these drugs are prescribed, they should only be used short term [1] [2] [3] [4] . However, research indicates that they are often prescribed long term [5, 6] . This is concerning, as BZDs and Z-drugs are known to have limited longterm therapeutic benefits, and also have adverse consequences for patients, such as dependency, daytime sedation, cognitive impairment and increased rates of falls and accidents [5] . Despite the risks, use of these drugs is particularly common in older people [7] . In a previous study, we conducted a systematic review and meta-synthesis which identified influences on general practitioner (GP) prescribing of these drugs. Here, findings suggested that GPs were more tolerant of long-term use in older compared with younger patients [8] .
In this study, we present a systematic review and meta-synthesis of literature from the perspective of patients, aiming to explore their experiences and perceptions of receiving BZDs and Z-drugs in primary care. We sought to identify factors which perpetuate the use of these drugs and to make recommendations for supporting safe, effective and patient-centred approaches to prescribing.
Methods
We conducted a systematic search for qualitative studies exploring patients' experiences and perceptions of primary care benzodiazepine and z-drug prescribing. The search encompassed six databases: MEDLINE, CINAHL, Social Science Citation Index, Science Citation Index, PsycINFO and AMED. A search strategy was initially developed for MEDLINE (Supplementary Table 1 , see electronic supplementary material [ESM] ), and subsequently adapted for the remaining databases. All databases were searched by May 2014.
Inclusion and Exclusion Criteria
Studies were included if they involved qualitative analysis of patient experiences of receiving BZDs and Z-drugs; were published between January 2000 and April 2014 to ensure relevance to current practice and the historical context of benzodiazepine prescribing; were published in a European language; and were conducted in Europe, the United States, Australia or New Zealand.
Studies which were not relevant to the focus of the review or were published outside these dates, languages and settings were excluded.
The initial search identified a total of 3975 papers. After removing duplicates, NS, CS and SYC examined either the title, abstract or full paper (where relevance was unclear), and identified seven papers for inclusion. Following a review of the reference lists of included papers and correspondence with the author of one of the included papers, two additional papers were identified for inclusion (Fig. 1) . One of these [9] was published after the cut-off date for the original search, but was included as it contained relevant data and had been accepted for publication in March 2014.
Data Extraction and Quality Assessment
Three researchers (CS, RP and SYC) independently extracted data from included studies on their aims, sample, method(s) of data collection and analysis, and theoretical perspective using a data extraction form created for the study; and assessed them using the Critical Appraisal Skills Programme (CASP) qualitative checklist [10] . A fourth researcher (NS) independently assessed all of the included papers for comparison. Agreement on ratings was reached after discussion as a group.
Data Synthesis
Data were analysed in NVivo 10 using thematic synthesis [11] . Initially, two researchers (CS and SYC) independently coded the 'results' sections of the included papers line-by-line, allocating codes based on the meaning of each line using an inductive approach. This resulted in the data being coded into 26 themes as free nodes in NVivo. We then met to discuss this initial coding, and make amendments required to ensure consistent coding into all of these themes across all papers. Next, as a group (CS, SYC, NS) we organised the codes into higher-level descriptive themes that encapsulated the meaning of groups of our initial codes. Finally, we considered these themes in relation to our research question, developing our final analytical themes (see below, and see Supplementary Table 3 [ESM] for further details of this process).
Results

Data Extraction
The nine included studies were published between 2003 and 2015 and were from four countries (Australia, Belgium, UK, USA) [9, [12] [13] [14] [15] [16] [17] [18] [19] . Participants in these studies were mainly older adults that were frequent users of BZDs.
Most studies contained a mixture of men and women, but there were more female participants overall. Studies were based on both semi-structured interviews and focus groups. Some studies employed mixed methods, in which case only the qualitative component was included in the meta-synthesis presented here. Various methods of analysis were employed in the studies including content analysis, thematic analysis and the constant comparative method (Table 1) .
Whilst all of the included studies contained data about patients' experiences and perceptions of receiving BZDs and Z-drugs, there was some variation in the primary focus of the papers. For three studies [12, 16, 17] , the primary focus was on insomnia, whilst for others the primary focus was on broader aspects of the use of these drugs and (in some cases) implications for service development.
Quality Assessment
The CASP criteria for qualitative research were applied to each paper. This checklist supports critical appraisal of research by asking reviewers to score papers against questions about ten domains that should be considered in qualitative research. Papers receive ratings of either 'zero', or 'one' in each domain. Papers only received a score of zero if the domain had not been addressed at all in the paper. The scores received ranged from eight to ten, indicating high quality. No studies were excluded on the basis of the quality assessment (Supplementary Table 2 , see ESM).
Data Synthesis
After initial coding and development of descriptive themes, we developed seven analytical themes, as detailed in the [18] , UK ''To conduct a survey of healthcare workers and high-dose benzodiazepine-dependent users to gauge opinion on improving services for this client group''. Focus groups were conducted to inform the questionnaire development The focus group that included patients ''consisted of community drug workers (n = 3) and highdose benzodiazepine-dependent clients (n = 9) who accessed their services Recruitment was achieved by contacting all five community drug services covering one innerLondon borough'' Clients were recruited by the community drug workers
Focus groups ''Both focus groups were facilitated by an independent non-clinical researcher and audiotaped. Two further researchers took notes to track turn-taking so that each individual's speech could be identified on the audiotape'' The audiotapes were transcribed verbatim and analysed using thematic analysis in NVivo Unclear following subsections (see Supplementary Table 3 , ESM, for more on this). These focused on patients' experiences and perceptions of receiving BZDs and Z-drugs. Within our data analysis we focused on insights gained from the data on strategies for encouraging safer prescribing of BZDs and Z-drugs. We organised the themes chronologically into a model representing a patient's journey from identifying that they have a health problem, through to using BZDs or Z-drugs, withdrawing from them, or (in some cases) continuing to use these medications contrary to medical guidelines (Fig. 2) .
Patients' Negative Perceptions of Insomnia and its Impact
Several studies, specifically those that focused on the management of insomnia, discussed the start of the patient journey-in this case, patients perceiving that they had a problem with sleep. Although other studies included patients using BZDs or Z-drugs in relation to other conditions (e.g. anxiety), we were unable to create equivalent themes for these conditions from the data available. Three studies [12, 16, 17] gave insight into patients' perceptions of insomnia, its causes and consequences, and the relationship between this condition and medical help-seeking. Patients perceived insomnia as involving difficulty falling asleep or waking after sleep onset:
They described difficulty with falling asleep…com-ments included…''I toss and turn'', ''It takes me four or five hours to fall asleep''…waking after sleep onset was also common [12] .
Many reported being able to get to sleep, but then waking in the early hours of the morning and being unable to return to sleep [16] .
The condition was attributed to a variety of causes including depression, shift work, post-traumatic stress disorder and lifestyle factors.
The studies pointed to the relationship between insomnia and other health conditions. This relationship was twoway; firstly, insomnia was cited as causing other health problems:
''I said to my doctor recently, 'when I die…I don't want breast cancer on my death certificate, I don't want emphysema, I want insomnia because I am sure that's at the root of all my problems''' [17] .
''I think a lot of it is because I'm so tired, that is what causes the depression'' [17] .
Secondly, insomnia was cited as being caused by other health problems. For example, arthritic pain and heart failure were cited as causing/precipitating insomnia; and patients viewed insomnia as being perpetuated by other comorbid physical and mental health conditions such as back pain, nocturia and anxiety. In one paper, adverse reactions to medication and the position of devices such as pacemakers were also said to perpetuate insomnia [12] . Insomnia was seen as having a deep and wide-reaching negative impact on patients' quality of life in both health and psychosocial areas, including patients being unable to enjoy activities because they were too tired:
''I was having marriage problems because of this thing of not sleeping'' [17] .
Insomnia often led to inability to do or enjoy previously enjoyable activities, such as concerts, travelling, shopping or visiting with grandchildren [12] .
They were plagued with memory problems, stating that their ''minds were not what they used to be'' and perceived that their memory problems are worse after ''a bad night'' [12] .
The perceived severity of this negative impact of insomnia was one factor which led patients to seek medical help.
Failed Self-Care Strategies
Studies showed that, prior to seeking help from a healthcare professional, patients with sleep problems and with difficulties coping with 'life stressors' [19] had tried to cope with their health problem in other ways, including attempting to distract themselves, lifestyle changes and using alternatives to prescription drugs:
Night time routines included playing 'mind games' to distract themselves from insomnia, worries and fears. The most common was going to bed late and watching television until falling asleep…Others used distraction through music, reading or driving in the car [12] .
Many patients had tried a range of alternatives to prescribed drugs for sleep problems for considerable periods before consulting. These included exercise, relaxation, over-the-counter drugs, herbal and miscellaneous remedies, or complementary therapies. Some had even read about cognitive behavioural therapy [17] .
''…try this tape, calming tapes and all this crap, that I have already tried anyway, also herbal stuff. Tried all the herbal stuff, you know in chemists'' [19] .
The perceived ineffectiveness of these strategies in relation to insomnia could trigger a consultation with a GP [17] .
Triggers to Medical Help-Seeking
Medical help-seeking was often triggered by the perceived ineffectiveness of self-help strategies, or (in the case of Fig. 2 Model of themes. This model shows our themes organised as a patient journey. It begins prior to medical help-seeking with two themes relating to patients' perception of their problem and steps that they take to address the problem before seeking medical help. It then shows how these themes can be triggers to medical help-seeking. The final group of themes relate to patients' perceptions and experiences of treatment insomnia), the perceived severity of the condition. Medical consultations were also triggered by significant life events, and pressure from others: Consultation was often triggered by significant life events or pressure from family and friends (social networks). By the time patients consulted with a GP or nurse prescriber, they had begun to see their problem as needing medical treatment rather than part of the range of normal human experience [17] .
'Life events' were also listed as a reason why people started using BZDs [19] .
Attitudes Towards Treatment Options and Service Provision
Eight studies included data on what patients wanted/expected when they sought help from a healthcare professional, both in relation to the specific type(s) of treatment offered, and other aspects of service delivery.
In terms of the specific type(s) of treatment offered, some patients were disappointed when a GP suggested treatments that they had already tried:
''…we'd tried [a sleep aid like] Nytol, the milky drinks at night, going to bed at a certain time and getting up at a certain time all that sort of thing, that's about all they discussed, and we'd already tried those'' [17] .
Some patients hoped or expected to receive medication for their problem when they consulted a healthcare professional, whilst others preferred not to use medication due to fear of side effects: Some patients welcomed a prescription they could use as needed. They found it empowering that a practitioner trusted them to take hypnotics appropriately. Others used the system to gain drugs as a fallback for the future [17] .
Others emphasised that they had not wanted sleeping tablets. Many patients preferred not to resort to hypnotic drugs because of fear of side-effects…Some found drugs unhelpful or counterproductive [17] .
When asked about their potential interest in behavioural sleep treatment, one participant stated: ''I'd eat a bucket of nails if you told me it would help me sleep.'' This was greeted with a resounding chorus of ''me too.'' The majority of the group agreed that they would like to learn more about sleep and insomnia and behavioural strategies to address it [12] .
In terms of other aspects of service delivery, patients discussed a desire for continuity of care, more discussion with a health professional prior to receiving a prescription, and longer consultation times. Patients wanted more detailed information, and for their problem to be taken seriously:
Pharmacists were seen as either not providing any information on the medications or inadequate information [19] .
There was a general consensus that to get detailed information from their GPs, they had to ask ''lots of questions'', and to ''probe'' to extract information. There was some dissatisfaction with the quality of consultations with GPs, and it was said that the short length of a consultation was a barrier to receiving a quality service. The issue of time was also raised when talking about alternative methods, but they ''would like to learn and receive information on them, as well as more information on the side-effects of the drugs they were already taking'' [16] .
Patients valued clinicians' empathy, listening, time given, and offer of explanations for treatment options…Continuity of care, a flexibility of approach, and a consistent or common approach within a practice were also found helpful [17] .
However, not all patients desired additional information/ discussion: …the conflict between the need for medication and the negative connotations attached to taking BZDs might explain the absence of a stated need for information. If patients had received more information on their medications, they might have had to give more thought to taking the prescription [13] .
Patients' knowledge of, and attitudes towards, potential side effects from medication could influence their patterns of use. In some cases, learning that a proposed medication was addictive meant that patients preferred alternative treatments. In others, patients saw this as less important, or were willing to pay this price for an improvement in the quality of their sleep:
''When he said that the tablets were addictive I didn't want to take the tablets. So I went another avenue, I went to the hypnotist'' [17] .
''My doctor took a lot of persuading to put me back on them [temazepam] . I said, 'look at my age…what the hell does it matter I've been addicted for 20 years I might die tomorrow'…so, he let me have them'' [17] .
The extent to which patients viewed becoming addicted to medication as a problem, and whether or not patients were willing to try alternatives, influenced their likelihood of withdrawal as shown under the 'withdrawal' section.
Finally, discussion of what patients wanted from services also included the idea of establishing specialised withdrawal services:
Some service users wanted a specialized benzodiazepine service: ''They should maybe have a place where they just…deal in benzos and nothing else…like the same as a methadone place'' [18] .
Varying Patterns of Use
Descriptions of patterns of medication use were included in most of the papers. With the exception of one paper [15] , where the majority of patients were reported to be taking their medication as prescribed, they encompassed a continuum from patients who tried to minimise their usage either through taking a smaller dose than prescribed or by taking them only as needed, through to patients who took more than they were prescribed: Many said they do not like to take sleeping tablets, and so only used them when needed [16] .
Respondents said they used only small doses, they consumed less medication than prescribed, and they took it only when necessary [13] .
''…he said one spoonful and 2 hours later I took another and another. The next night I drank twothirds of the bottle'' [17] .
Patients' own awareness and fear of the dangers of addiction to BZDs contributed to a desire to take only the minimum dosage of BZDs by some patients:
Perceiving that an increase in one's prescribed benzodiazepine dose would result in addiction kept informant's benzodiazepine use at regular, low doses. Evie: ''I'm afraid to take more than they tell me to of that kind of medicine (benzodiazepines)… because I would like to not be taking things that are addictive'' [14] .
Withdrawal
Several papers (particularly [14, 15, 19] ) contained information on withdrawal strategies and enablers and barriers to withdrawal. Strategies for withdrawal included taking an individually tailored approach and focussing on alternative strategies for coping:
Changes in cognition were the most prevalent strategy….individually tailored dose reduction schedules were reported as useful….continuing a non-using lifestyle was assisted by being involved in a range of activities such as yoga… [19] .
Reasons for withdrawal included a realisation that their use of the drugs was interfering with their life and the people around them:
Participants typically said they ceased use when they became unhappy with their current lifestyle; realised their use of the drug was self-destructive [19] .
Numerous barriers to withdrawal were discussed in the papers. These included a perception from patients of being unable to reduce medication use and fear of what would happen if they did discontinue-either based on imagined negative consequences or past experiences. Psychological rather than physical dependence was the predominant concern:
''I really, I don't really think I can handle things without my meds. I mean I'm just really, really, really dependent on them at this point. All of them'' [14] .
''I just can't do it. Are you trying to tell me that I should stop or not take it? I'd be miserable. Are you gonna tell him [the physician] not to prescribe it anymore? Please don't tell him not to give it to me'' [15] .
With minimal probing, patients' seeming willingness to consider tapering or substitution of alternative medications shifted to an admission that this would be an unacceptable option. Patients' responses ranged from the more simply expressed reluctance, ''I need it'' or ''I don't want to change,'' to more sophisticated explanations, i.e., anticipation that the taper process would be negative [15] .
Links between feelings and beliefs about dependence on medication and the ongoing use of medication were seen in two papers:
Self-reported benzodiazepine dependence was associated with perceptions of being unable to reduce benzodiazepine use or a desire to discontinue use as well as feeling reliant on benzodiazepines to be comfortable and able to handle life [14] .
''…too many other competing demands to address the benzodiazepine: I always have like some other issue other than, you know, that one pill'' [15] .
In addition to barriers internal to the patient, barriers that were external to the patient were also discussed, such as lack of support from GPs, a need for specialist withdrawal services, and absence of an appropriate support network:
''I wasn't making contact with anyone who could give me some clues on how to deal with benzos. For me the lack of contact with people who had done it. I went to [Narcotic Anonymous] and at one time I was going to Al-Anon as well, but I wasn't making contact with anybody who could give me some clues on how to deal with benzos'' [19] .
Reasons for Initial or Ongoing Use
Reasons given for the initial use of medication included patient circumstances; life events; specific health conditions such as sleep problems, anxiety or pain; the perception that medication was effective; and the fact that the medication was prescribed by a GP. Anxiety around living alone could also be an important trigger for medication use, and a reason for ongoing use [9] .
Many patients reported a lack of knowledge or concern about the long-term use of medication:
Patients viewed chronic stable benzodiazepine use as responsive to a need and as a great benefit. In doing so, they minimized, or even denied, physical addictive properties or potential for misuse or inappropriate use [15] .
Reasons for ongoing use included patients feeling that they could live their lives more normally whilst using medication:
For the most part, patients saw benzodiazepines not as a life-enhancing luxury but as restorative and necessary to maintain a normal life, and anticipated that life without benzodiazepines would be of a decidedly lower quality [15] .
Typically, participants found that benzodiazepines alleviated negative feelings enabling them to cope more effectively with stressful situations; control panic and anxiety symptoms; allowed them to relax; or reduced feelings of aggression…In addition, they felt better and more confident and coped with day-today adverse events [19] .
A passive feeling of trust in GPs was also described, such that patients expected that their GP would initiate a change in their BZD use if it were needed:
Patients said that the relationship with their physicians was based on trust, thereby explaining why they did not need more information. They said they presumed the doctor would always act in their best interest: ''I think it is like when you go to a caterer, we don't ask him how he has made the food'' [13] .
Discussion
This paper synthesised the findings of qualitative research into patients' experiences and perceptions of receiving BZDs and Z-drugs and produced a model of patients' experiences and perceptions based on the patient journey. Whilst variation across the studies in terms of their participants produced some subtle differences in findings (for example, heart failure patients cited pacemakers as a cause of insomnia), we were still able to identify a number of common themes.
Strengths and Limitations
This is the first meta-synthesis of literature on patients' experiences and perceptions of BZD and z-drug prescribing. The studies identified through the systematic review were conducted in a range of settings between 2003 and 2014. The studies mainly included older adults that were frequent users of BZDs for insomnia, but there was some variation between studies in how the populations were selected and the primary focus of the paper. For example, one study was based on the perceptions of patients with heart failure [12] , whereas another focused on experiences of isolation and loneliness in older BZD users [9] . There is a risk that the particularities of the individual studies are lost in a meta-synthesis. To prevent this we have provided descriptions of each study in Table 1 .
As with all thematic syntheses, we offer our interpretation of findings and attempt to 'go beyond' the literature to answer a particular question. We have employed a number of techniques to enhance the validity of our findings. The analysis was undertaken by reviewers from different backgrounds and discussed with a wider multidisciplinary team to consider any bias that may have been introduced. We also included direct quotations from the papers to enable critical appraisal of our interpretations and to show the range of studies that contributed to each theme.
Comparison with the Wider Literature
Numerous factors influence how we monitor, interpret and respond to bodily indicators ('illness behaviour') [20] . Previous research shows that many people with insomnia or anxiety disorders do not seek medical help for their disorder, and often people seek advice from informal helpers or try self-help treatments prior to seeking medical help [21] [22] [23] [24] . Our findings echo and add to such previous research on the determinants of help-seeking, in particular in relation to insomnia. Data from our included studies showed that help-seeking for insomnia is triggered by patients viewing the negative functional impact of insomnia as 'severe enough' to justify medical intervention, the perceived ineffectiveness of those self-help strategies that were used, significant life events and pressure from others.
Our findings show that several factors perpetuated the use of BZDs and Z-drugs. Firstly, psychological dependence-the 'withdrawal' and 'reasons for initial or ongoing use' themes showed that patients viewed their medication as effective and expressed fear that tapering use would have negative consequences, and that withdrawal would leave them unable to cope. Secondly, absence of supportthe 'attitudes towards treatment options and service provision' and 'withdrawal' themes showed that some patients were dissatisfied with GP consultations and there were a number of things that could be done to improve service provision. There was a perceived lack of support from GPs to discontinue use, and the 'reasons for initial or ongoing use' theme indicated that patients trusted their GP to recommend withdrawal if it was the best option for them, and GPs had not done this. Some patients expressed a desire for a specialised support network or service for withdrawal from BZDs. Finally, the 'reasons for initial or ongoing use' theme showed that patients reportedly denied, or stated that they were unaware of the side effects of medication.
These findings resonate with work on patient barriers and enablers for deprescribing [25] , which, amongst other things, identified the extent of a patient's agreement with the 'appropriateness' of cessation, fear of cessation and the presence or absence of a process for cessation as key themes.
Implications for Future Practice and Research
Exploring this literature has enabled us to identify points throughout the patient journey where strategies could be introduced to support both healthcare professionals 1 and patients to reduce misuse of BZDs and Z-drugs, and find effective alternative ways to manage their health condition(s). These are summarised in Table 2 .
Through considering the implications of our analytical themes and the wider literature around strategies for reducing inappropriate use of BZDs and Z-drugs and supporting patients with conditions for which these drugs may be prescribed, we identified three main strategies which may support safer prescribing.
Firstly, creation of educational resources could be helpful. Direct patient education has previously been shown to be effective in encouraging patients to discuss discontinuing BZD use with physicians or pharmacists and achieving desistance or dose reduction when compared with usual care [26] . Our study showed that patients perceived their own self-help strategies to be ineffective prior to consulting a healthcare professional and that, in some cases, patients denied or were unaware of the side effects of BZDs/Z-drugs. Educational resources could detail what guidelines recommend in terms of support for insomnia, anxiety or pain, outlining appropriate self-care strategies and how to implement them, helping patients to have realistic expectations of what treatments might achieve (e.g. what 'normal' or 'good quality' sleep is), and directing patients towards alternative treatments such as (online) cognitive behavioural therapy (CBT). These resources should also detail the potential side effects of using BZDs and Z-drugs, and stress that they are only recommended for short-term use followed by staged withdrawal at a pre-determined time. Appropriate dissemination of such resources (online, and via healthcare professionals such as GPs, practice nurses and community pharmacists) would raise both patients' and healthcare professionals' awareness of alternatives to medication and the risks of prescribing or taking medication, particularly for older adults, thus modifying demand for pharmacological interventions both prior to and at the point of access. Resources could include a sleep diary that could be used to develop tailored provision of alternative treatments and/or stepped withdrawal.
Secondly, as suggested in our previous research [8] , alternatives such as CBT that have been shown to be effective and are recommended in clinical guidelines need to be made more widely available. One reason for medical help-seeking is that patients perceive the negative impact of a condition to be serious enough to warrant medical intervention. CBT techniques can be used to identify and reframe negative views about health conditions (referred to as 'cognitive restructuring', 'cognitive reframing' or 'positive reframing') [27] . Research in pain management has found that a patient accepting their condition can itself lead to positive outcomes [28] , and (computerised) CBT has been shown to be effective for patients with anxiety disorders and for patients with insomnia [29] [30] [31] . Alongside directing 'new' patients to alternatives, further research is needed to ascertain the efficacy of different approach(es) to deprescribing (e.g. patient education, group therapy, mixed interventions). Here, consideration needs to be given to the influence of patient characteristics (including things like comorbidities) on this [32] . Findings of such research should be shared with a wide range of healthcare professionals.
Thirdly, this study suggests extending the healthcare professional-patient dialogue in a targeted way at the point of help-seeking to explore and encourage the use of non-pharmacological treatments, clarify issues around self-help strategies and how best to implement them, encourage open and honest dialogue, and ensure that patients know that sleep problems are taken seriously. Adherence to self-help treatments is an important consideration, with previous research showing this to be at approximately 50 % for technology-mediated insomnia treatments (i.e. those delivered via technology rather than face-to-face) [33] . Part of the ongoing dialogue between the healthcare professional and patient may be to try to maintain a higher level of adherence to ensure maximum effectiveness of nonpharmacological treatments.
As set out in NICE guidelines [1] [2] [3] , pharmacological interventions should be a last resort. Previous work shows that GPs sometimes assume that patients want medication or would be resistant to the idea of withdrawing from medication [8, 34] . GPs and other healthcare professionals should be made aware of the potential influence of perceived patient expectations on prescribing and should be encouraged to directly discuss patients' preferences with them. As the literature reviewed here shows, patients' patterns of use and likelihood of withdrawal are influenced by their understanding of and attitude towards the risk of addiction. Not all patients want medication, and whilst some patients are not concerned about the risk of addiction, others would prefer to try alternative treatments to avoid this risk.
At follow-up appointments, various healthcare professionals including community pharmacists can focus on medication management, ascertain patients' patterns of medication use (rather than assuming that they use it as directed), discuss the need for staged withdrawal, and discuss issues around psychological dependence and any changes in patients' circumstances.
GPs and patients both identify short consultation times as a problem, and work pressures may pose a barrier to extending the GP-patient dialogue. However, personalised support can be delivered by a range of healthcare professionals including community pharmacists, and in the long term, this may save time as patients will not be returning for repeat prescriptions. The potential benefits of this could be the subject of future research.
Differences in perspectives from the healthcare professional and patient of the problem and its solution are important when considering how to reduce inappropriate prescribing. Some of these differences come to light when comparing the results of this meta-synthesis of patient perspectives with our earlier meta-synthesis on GP perspectives [8] . GPs expressed concerns that there were a lack of alternatives to medication, and when these were available they were time consuming and difficult to access [8] , whereas in this meta-synthesis we identified that patients felt they had tried alternatives to medication before seeing their GP, but that these were ineffective. However, the alternatives tried were not necessarily those that would be recommended by a healthcare professional. Establishing a shared concept between patient and GP of the value of alternatives to medication and likelihood of success could help patients to then re-explore these avenues under the guidance of their GP, leading to greater success in their use.
Conclusion
Benzodiazepines and Z-drugs are often inappropriately prescribed long term for the treatment of insomnia, pain and anxiety disorders, particularly in older people. Inappropriate use is perpetuated by patients' psychological dependence on these drugs, an absence of support to discontinue use, and patients' lack of awareness of, or denial of, the side effects of these medications. Safer prescribing could be achieved through the creation of educational resources, increased availability and use of effective alternatives recommended in clinical guidelines such as CBT, and an extended GP-patient dialogue.
